Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas...
European equities moved higher as easing US shutdown risks lifted sentiment, offering selective opportunities for investors focused on cyclicals and macro-sensitive positions...
Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance...
Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term...
Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy...
A U.S. court ruling reignited European utilities, retail spin-offs drew attention, and chip equipment guidance cast a shadow, setting a distinctive tone for investors...
Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index...
FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth...
Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas...
European equities moved higher as easing US shutdown risks lifted sentiment, offering selective opportunities for investors focused on cyclicals and macro-sensitive positions...
Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance...
Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term...
Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy...
A U.S. court ruling reignited European utilities, retail spin-offs drew attention, and chip equipment guidance cast a shadow, setting a distinctive tone for investors...
Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index...
FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth...
